Main Banner Desktop
hubeinewdesheng

Hubei New Desheng Materials Technology Co., Ltd

Unverified company Unverified company
  • Imagem 1

NSP-DMAE-NHS ester CAS194357-64-7


Unit Price:

Not informed

FOB Price:

Not informed

Minimum Order Quantity:

Not informed

Type of Payment:

L/C (Letter of Credit)

Preferred Port:

Not informed

Reference:

Not informed


Description

[English name] NSP-DMAE-NHS

[Chinese name] Acridinium ester NSP-DMAE-NHS

[CAS#]194357-64-7

[Molecular weight] 590.60

[Appearance] Yellow solid or powder

[Formula] C30H26N2O9S

[Storage condition] Room temperature, away from light and moisture

[Application] It is used in chemiluminescence and immunoassay, receptor analysis, nucleic acid and peptide detection.

[Product advantage] Purity: ≥ 98% (HPLC), good water solubility, stable process, little difference between batches.

[Properties] Acridinium ester is a kind of chemical substance that can be used as a chemiluminescent marker. In the alkaline H2O2 solution, when the molecule of acridinium ester is attacked by hydrogen peroxide ion, the substituent on acridinium ring can form unstable dioxane with C-9 and H2O2 (hydrogen peroxide) on acridinium ring, which is decomposed into CO2 and N-methylacridone in the excited state.

  • NSP-DMAE-NHS ester
  • CAS194357-64-7

Production Capacity:

Not informed

Delivery Timeframe:

Not informed

Incoterms:

CIF - Cost, Insurance and Freight

Packaging Details:

Not informed


More about
Hubei New Desheng Materials Technology Co., Ltd

icone de usuario

Not informed

sales icon

Not informed

icone de exportar

Not informed

Not informed

Year

Established


Business type
  • Industry / Manufacturer
  • Importer / Trading Company

Keywords
  • Kapom
  • buffer
  • separator

Contact and location
  • icone de usuario Ming Yu
  • icone de telefone +86 xxxxxxxx
  • map-marker ezhou / 湖北 | China

Make your Request!

Make your Request!

Start conversation
logo-Whatsapp icon-checked-none

Hello 👋!
Can we help you?

Fill in your name and phone number 😁

Start conversation Start conversation